SCHOTT Pharma AG & Co. KGaA (1SXP XETRA) stock market data APIs
€14.8671
0.21(1.4%)
as of January 2, 2026
Try our APIs with
free plan!
SCHOTT Pharma AG & Co. KGaA Financial Data Overview
Price chart is built with
Anychart
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Prev. Close
14.8671
Open
15.081
High
15.1864
Low
14.7487
52 wk Range
14.56-30.25
Market Cap
2 217 M
P/E Ratio
15.1753
Shares Outstanding
151 M
Revenue
986 M
EPS
0.22
Dividends (Yield)
0.0119
Beta
1.113
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with SCHOTT Pharma AG & Co. KGaA (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SCHOTT Pharma AG & Co. KGaA data using free add-ons & libraries
Get SCHOTT Pharma AG & Co. KGaA Fundamental Data
SCHOTT Pharma AG & Co. KGaA Fundamental data includes:
- Net Revenue: 986 M
- EBITDA: 260 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-11
- EPS/Forecast: 0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SCHOTT Pharma AG & Co. KGaA News
New
A Look At The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Key Insights SCHOTT Pharma KGaA's estimated fair value is €21.38 based on 2 Stage Free Cash Flow to Equity Current share price of €18.32 suggests SCHOTT Pharma KGaA is potentially trading close t...
What Does SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Share Price Indicate?
While SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the XTRA over the last few months, incre...
Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
SCHOTT Pharma KGaA (ETR:1SXP) has had a rough three months with its share price down 28%. But if you pay close attention, you might gather that its strong financials could mean that the stock could po...
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
SCHOTT Pharma KGaA (ETR:1SXP) has had a rough three months with its share price down 5.4%. However, stock prices are usually driven by a company’s financial performance over the long term, which in ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
